Cell and Gene Therapy in Oncology, Part II
Summary
Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the second in a series focused on cell and gene therapies, experts from our Policy and Market Access practices discuss value-based payment arrangements in cell and gene therapies, and the role they play in facilitating access to these therapies.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
To listen to this video as a podcast, please visit our podcast page.
On the Record: Health Plan and Provider Perspectives Video Series
Federal and state policymakers are actively shaping health coverage and access, and we’re here to explain exactly what these changes mean for plans and providers.
Watch the video series
Connect with the team directly
Services
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.
